Old Web
English
Sign In
Acemap
>
Paper
>
Ultratrace meta-211At-astatobenzylguanidine (211At-MABG) for targeted radiotherapy of neuroendocrine cancer
Ultratrace meta-211At-astatobenzylguanidine (211At-MABG) for targeted radiotherapy of neuroendocrine cancer
2014
Ann-Marie Chacko
Vandana Batra
Catherine Hou
John L. Mikitsh
Maria Gagliardi
Richard Freifelder
Alexander V. Kachur
Mehran Makvandi
John M. Maris
Daniel A. Pryma
Keywords:
Targeted Radiotherapy
211At-MABG
Oncology
Neuroendocrine Cancer
Medicine
Internal medicine
Correction
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]